Evidence map›Paper›PMID 29881742›Full record

ArticleEGEMS (Washington, DC)2017

Generalizability of Indicators from the New York City Macroscope Electronic Health Record Surveillance System to Systems Based on Other EHR Platforms.

Katharine H McVeigh, Elizabeth Lurie-Moroni, Pui Ying Chan, Remle Newton-Dame, Lauren Schreibstein, Kathleen S Tatem, Matthew L Romo, Lorna E Thorpe, Sharon E Perlman

Abstract read
In one paragraph

Article in EGEMS (Washington, DC), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katharine H McVeighNew York City Department of Health and Mental Hygiene.
Elizabeth Lurie-MoroniNew York City Department of Health and Mental Hygiene.
Pui Ying ChanNew York City Department of Health and Mental Hygiene.
Remle Newton-DameNew York City Department of Health and Mental Hygiene.
Lauren SchreibsteinNew York City Department of Health and Mental Hygiene.
Kathleen S TatemNew York City Department of Health and Mental Hygiene.
Matthew L RomoNew York City Department of Health and Mental Hygiene.
Lorna E ThorpeNew York University School of Medicine, Department of Population Health.
Sharon E PerlmanNew York City Department of Health and Mental Hygiene.

Funding

PPHF-13 NY CITY DEPARTMENT OF HEALTH & MENTAL HYGIENE 2011-2012 ENVIRONMENTAL PUBU38EH000939 · EH · NEW YORK CITY HEALTH/MENTAL HYGIENE · PI MCKELVEY, WENDY · 2011 to 2015
$4.8M
NCEH CDC HHS U38 EH000939
6 · The paper itself

Abstract

introductionThe New York City (NYC) Macroscope is an electronic health record (EHR) surveillance system based on a distributed network of primary care records from the Hub Population Health System. In a previous 3-part series published in

methodsWe abstracted primary care chart data from more than 20 EHR software systems for 142 participants of the 2013-14 NYC Health and Nutrition Examination Survey who did not contribute data to the NYC Macroscope. We then computed the sensitivity and specificity for indicators, comparing data abstracted from EHRs with survey data.

resultsObesity and diabetes indicators had moderate to high sensitivity (0.81-0.96) and high specificity (0.94-0.98). Smoking status and hypertension indicators had moderate sensitivity (0.78-0.90) and moderate to high specificity (0.88-0.98); sensitivity improved when the sample was restricted to records from providers who attested to Stage 1 Meaningful Use. Hyperlipidemia indicators had moderate sensitivity (≥0.72) and low specificity (≤0.59), with minimal changes when restricting to Stage 1 Meaningful Use. DISCUSSION: Indicators for obesity and diabetes used in the NYC Macroscope can be adapted to other EHR surveillance systems with minimal validation. However, additional validation of smoking status and hypertension indicators is recommended and further development of hyperlipidemia indicators is needed.

conclusionOur findings suggest that many of the EHR-based surveillance indicators developed and validated for the NYC Macroscope are generalizable for use in other EHR surveillance systems.

Identifiers

PMID29881742
PMCPMC5982844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.